Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes”

2 trials

Showing 2 of 2 results

Post-approval studies (Phase 4)UnknownNCT04584242
What this trial is testing

Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

Who this might be right for
Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes
Yonsei University 40
Post-approval studies (Phase 4)UnknownNCT05473806
What this trial is testing

Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes

Who this might be right for
Hepatitis B, ChronicFibrosis, LiverDiabetes Mellitus, Type 2
Seung Up Kim 28

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation